Bacterial
Clostridium Difficile Infection
-
-
0
Could RBX2660 be the microbiome-based solution to C. diff infection recurrence?
-
0
FDA approves Merck & Co.’s Ebola vaccine Ervebo: January’s industry headlines
E. Coli
-
0
Antibodies from maternal microbiota could protect newborns from infection
-
0
Multidrug efflux systems: information on evolution and mechanisms uncovered
-
0
E. coli created with world’s first synthetic and redesigned genome
H. Pylori
-
0
Organoids: a new model to study infectious diseases?
-
1
Infographic: The microbiome and infectious diseases
-
0
Are flies a significant method of bacterial transmission?
MRSA
-
0
The race for COVID-19 treatments and vaccines: February’s industry headlines
-
0
New study reveals how the household environment influences MRSA spread
-
2
Novel vaccine candidate for Staphylococcus aureus shows 80% efficacy in mice
Salmonella
-
1
Application of bacteriophages to overcome antimicrobial resistance
-
0
Whole-genome sequencing of Salmonella enterica Serovar Typhi reveals new antimicrobial resistant isolates
-
0
Novel models for enteric infections – an interview with the Faherty Lab